Spinal Tech

After the Trump administration announced new tariffs on imported steel and aluminum, other countries are deciding how to respond. The Trump administration received a list of Chinese products and ingredients that could be subject to 25 percent tariffs on April…

The global thoracolumbar spine devices market is expected to grow through 2022, according to a ResearchAndMarkets report.

Orthofix will likely see $107.65 million in sales for the first quarter of 2018, based on a Zacks analysis, according to The Ledger Gazette.

Xtant Medical and Healthcare International Partners signed a three-year agreement to expand Xtant's products in Latin American markets.

The FDA cleared 15 spine-related devices in March.

Professor Yong QIU performed China's first spinal deformity surgery using SpineGuard's PediGuard device.

Stryker's neurotechnology and spine division is anticipated to see growth in the first quarter of 2018, pushing the company's overall growth, according to Zacks.

Kineta Chronic Pain signed an agreement with pharmaceutical leader Genentech to develop a non-opioid chronic pain treatment, according to CNBC.

The FDA proposed steps to improve government oversight of medical devices, according to The Seattle Times.

Here are nine key notes on orthopedic and spine device companies from the past week.